NWS vs ORMP
NWS (NWS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
NWS (NWS) common stock.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
NWS currently screens at market cap $0. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the NWS and ORMP stock pages for the full models.
Not investment advice.